Georgia's PM questions costly Duchenne treatment amid budget concerns
Georgian Prime Minister Irakli Kobakhidze has called for careful consideration before funding medication for children with Duchenne muscular dystrophy. He stressed that the government must weigh the decision’s effectiveness against its cost to taxpayers. The proposed budget for the treatment ranges between 50 and 60 million GEL of public funds. Kobakhidze highlighted the need for responsibility in spending, warning that past decisions made under public pressure had led to wasted resources. He cited examples where tens of millions were spent without clear benefits. The Prime Minister also cautioned against rushing into a choice that might only profit what he called a 'pharmaceutical mafia'.
He insisted that further discussions should take place within the Ministry of Health, where the necessary expertise exists. Despite this, he remained open to changing the government’s stance if new arguments emerge during consultations.
The Prime Minister also announced readiness to engage with all stakeholders, including the Church and the Catholicos-Patriarch of Georgia. While acknowledging the political appeal of funding the treatment, he reiterated that the priority must be rational and effective use of public money. The government will continue assessing whether the proposed spending will deliver real results. Kobakhidze’s remarks suggest a cautious approach, balancing public health needs with financial accountability. A final decision will follow further expert consultations and stakeholder discussions.
Read also:
- American teenagers taking up farming roles previously filled by immigrants, a concept revisited from 1965's labor market shift.
- Weekly affairs in the German Federal Parliament (Bundestag)
- Landslide claims seven lives, injures six individuals while they work to restore a water channel in the northern region of Pakistan
- Escalating conflict in Sudan has prompted the United Nations to announce a critical gender crisis, highlighting the disproportionate impact of the ongoing violence on women and girls.
